Celalettin VATANSEV, Serkan KÜÇÇÜKTÜRK, Adem KÜÇÜK, Mehmet Ali KARASELEK, Resül YILMAZ, Ahmet TOPAL, Hülya VATANSEV, Şebnem YOSUNKAYA

Evaluation of coagulation with TEG in patients diagnosed COVID-19

Background and aim:A high D-dimer level may indicate the risk of coagulopathy and mortality in COVID-19 patients. Thromboelastography (TEG) is a test that evaluates clot formation and fibrinolysis in real-time, unlike routine coagulation tests. The study aimed to investigate the coagulation process with TEG in patients diagnosed with COVID-19. Materials and Methods: The study was performed at our university hospital, chest diseases outpatient clinic as a cross-section study. A total of 51 patients with 23 high D-dimer levels group (HDG) and 28 low D-dimers group (LDG) were included in the study. TEG analysis was performed at the pretreatment evaluation in these two groups. Results: D-dimer and fibrinogen levels of the HDG were higher than those of the LDG (550 vs. 90 ng/mL, p < 0.001; 521 vs. 269 mg/ dL, p < 0.001, respectively). In TEG analysis, HDG’s R and K values were lower than LDG, and HDG’s Angle, MA, and CI values were higher than LDG (p = 0.037; p < 0.001; p < 0.001; p < 0.001; p < 0.001, respectively). ROC curve analysis suggested that the optimum TEG parameters cut-off points for thrombosis risk were as below: for K was ≤2.1 min, for R was ≤6.1 min, for Angle was >62°, MA was 60.4 mm. Conclusion: Our study showed that the risk of thrombosis might increase in COVID-19 patients who are not hospitalized in the intensive care unit. Thrombosis risk should be investigated with TEG analysis and laboratory tests in every patient diagnosed with COVID-19, and treatment should be started for risky patients.

PDF

___

1. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology. 2020; 38 (1): 1-9. doi: 10.12932/AP-200220- 0772
2. Mortus JR, Manek SE, Brubaker LS, Loor M, Cruz MA et al. Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill. JAMA Network Open. 2020; 3 (6): e2011192. doi: 10.1001/jamanetworkopen.2020.11192
3. Yuriditsky E, Horowitz JM, Merchan C, Ahuja T, Brosnahan SB et al. Thromboelastography profiles of critically ill patients with coronavirus disease 2019. Critical Care Medicine. 2020; 48 (9): 1319-1326. doi: 10.1097/CCM.0000000000004471
4. Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thrombosis Research. 2020; 192: 152-160. doi: 10.1016/j. thromres.2020.05.039
5. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020; 136 (4): 489-500. doi: 10.1182/blood.2020006520
6. Harahsheh Y, Ho KM. Use of viscoelastic tests to predict clinical thromboembolic events: A systematic review and meta‐analysis. European Journal of Haematology. 2018; 100 (2): 113-123. doi: 10.1111/ejh.12992
7. Saseedharan S, Talla VB, Chiluka A. Thromboelastography profile of patients with COVID-19 admitted to intensive care unit: A single-center retrospective study from India. Indian Society of Critical Care Medicine. 2020; 24 (12): 1218. doi: 10.5005/jp-journals-10071-23675
8. Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C et al. Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. Journal of Thrombosis and Haemostasis. 2020; 18 (7): 1738-1742. doi: 10.1111/jth.14850
9. Salem N, Atallah B, El Nekidy WS, Sadik ZG, Park WM et al. Thromboelastography findings in critically ill COVID-19 patients. Journal of Thrombosis and Thrombolysis. 2021; 51 (4): 961-965. doi: 10.1007/s11239-020-02300-7
10. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH et al. Radiological society of north America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the society of thoracic Radiology, the American college of Radiology, and RSNA. Radiology Cardiothoracic Imaging. 2020; 2 (2): e200152. doi: 10.1148/ryct.2020200152
11. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23): 2033- 2040. doi: 10.1182/blood.2020006000.
12. Hightower S, Ellis H, Collen J, Ellis J, Grasso I et al. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019. Thrombosis Research. 2020; 195: 69-71. doi: 10.1016/j.thromres.2020.07.013
13. Lorenzo C, Francesca B, Francesco P, Elena C, Luca S et al. Acute pulmonary embolism in COVID-19 related hypercoagulability. Journal of Thrombosis and Thrombolysis. 2020; 50 (1): 223-236. doi: 10.1007/s11239-020-02160-1
14. Raval JS, Burnett AE, Rollins‐Raval MA, Griggs JR, Rosenbaum L et al. Viscoelastic testing in COVID‐19: a possible screening tool for severe disease? Transfusion. 2020; 60 (6): 1131-1132. doi: 10.1111/trf.15847
15. Zhang L, Yan X, Fan Q, Liu H, Liu X et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. Journal of Thrombosis and Haemostasis. 2020; 18 (6): 1324-1329. doi: 10.1111/jth.14859
16. Uyar E, Merdin A, Yamanyar S, Ezgü MC, Artuk C et al. Could serum albumin value and thrombocyte/lymphocyte ratio be an important prognostic factor in determining the severity of COVID 19? Turkish Journal of Medical Sciences. 2021; 51 (3): 939-946. doi: 10.3906/sag-2008-285
17. Asan A, Üstündağ Y, Koca N, Şimşek A, Sayan HE et al. Do initial hematologic indices predict the severity of COVID-19 patients? Turkish Journal of Medical Sciences. 2021; 51 (1): 39- 44. doi: 10.3906/sag-2007-97
18. Song JC, Wang G, Zhang W, Zhang Y, Li WQ et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Military Medical Research. 2020; 7: 1-10. doi: 10.1186/s40779-020-00247-7
19. Jiang L, Li Y, Du H, Qin Z, Su B. Effect of Anticoagulant Administration on the Mortality of Hospitalized Patients With COVID-19: An Updated Systematic Review and MetaAnalysis. Frontiers in Medicine. 2021; 8: 698935. doi: 10.3389/ fmed.2021.698935
20. Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. Journal of Thrombosis and Haemostasis. 2020; 18 (8): 1859-1865. doi: 10.1111/jth.14929
21. Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. Journal of Thrombosis and Haemostasis. 2020; 50 (1): 72-81. doi: 10.1007/s11239-020- 02138-z